Dimensional Fund Advisors’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Buy
390,165
+176,701
+83% +$549K ﹤0.01% 2828
2025
Q4
$670K Buy
213,464
+36,353
+21% +$115K ﹤0.01% 2925
2025
Q3
$513K Sell
177,111
-21,575
-11% -$48.7K ﹤0.01% 2988
2025
Q2
$403K Sell
198,686
-38,872
-16% -$67.6K ﹤0.01% 3025
2025
Q1
$445K Buy
237,558
+106,148
+81% +$267K ﹤0.01% 3018
2024
Q4
$355K Buy
131,410
+74,358
+130% +$232K ﹤0.01% 3084
2024
Q3
$216K Sell
57,052
-3,146
-5% -$11K ﹤0.01% 3158
2024
Q2
$240K Buy
60,198
+446
+0.7% +$1.48K ﹤0.01% 3139
2024
Q1
$177K Hold
59,752
﹤0.01% 3200
2023
Q4
$299K Hold
59,752
﹤0.01% 3136
2023
Q3
$170K Sell
59,752
-1,200
-2% -$3.65K ﹤0.01% 3239
2023
Q2
$180K Buy
60,952
+14,705
+32% +$32.1K ﹤0.01% 3254
2023
Q1
$108K Buy
+46,247
New +$107K ﹤0.01% 3291
2022
Q3
Sell
-12,707
Closed -$45K 3487
2022
Q2
$45K Hold
12,707
﹤0.01% 3397
2022
Q1
$51K Hold
12,707
﹤0.01% 3460
2021
Q4
$63K Hold
12,707
﹤0.01% 3470
2021
Q3
$85K Hold
12,707
﹤0.01% 3444
2021
Q2
$101K Hold
12,707
﹤0.01% 3407
2021
Q1
$97K Hold
12,707
﹤0.01% 3354
2020
Q4
$66K Hold
12,707
﹤0.01% 3303
2020
Q3
$62K Hold
12,707
﹤0.01% 3292
2020
Q2
$86K Buy
12,707
+1,415
+13% +$10.3K ﹤0.01% 3287
2020
Q1
$78K Buy
+11,292
New +$88.3K ﹤0.01% 3292

Other funds holding ACIU

Dimensional Fund Advisors's ACIU Position: Q1 2026 in Review

Dimensional Fund Advisors increased its AC Immune (ACIU) stake by 83% in Q1 2026, buying an estimated $549K and bringing the position to 390,165 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

Dimensional Fund Advisors first reported a position in ACIU in Q1 2020 and has held it in 23 quarters since. 46 funds tracked by Wall St. Rank hold ACIU as of Q1 2026.

  • Dimensional Fund Advisors held 390,165 shares of AC Immune worth $1.07M as of Q1 2026.
  • Dimensional Fund Advisors bought 176,701 AC Immune shares in Q1 2026, an estimated $549K.
  • AC Immune made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2828 holding.
  • Dimensional Fund Advisors first reported a position in AC Immune in Q1 2020 and has held it in 23 quarters since.
  • 46 funds tracked by Wall St. Rank held AC Immune as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.